Aritmilere Yaklaşım
Synopsis
The heart is an autonomous organ that generates its own electrical impulses via the sinoatrial (SA) and atrioventricular (AV) nodes, where normal propagation from the SA node defines normal sinus rhythm, while deviations are termed dysrhythmias or arrhythmias, classified broadly into bradyarrhythmias and tachyarrhythmias. Bradyarrhythmias, where the heart rate is typically below 60 bpm, arise from conduction or impulse generation defects in the SA node, AV node, or His-Purkinje system, and are managed using atropine, temporary or permanent pacemakers, adrenaline, dopamine, theophylline, or immediate cardiopulmonary resuscitation (CPR) in cases of asystole and pulseless electrical activity. Tachyarrhythmias are categorized into supraventricular (narrow QRS) and ventricular (wide QRS) types; supraventricular tachyarrhythmias are treated with vagal maneuvers, beta-blockers, calcium channel blockers, adenosine, antiarrhythmic drugs, synchronized cardioversion, and radiofrequency ablation, while atrial fibrillation—the most common arrhythmia—requires strict rate/rhythm control along with anticoagulation therapy to prevent thromboembolism. Ventricular tachyarrhythmias (VT and VF), representing the leading cause of sudden cardiac death, demand immediate defibrillation (unsynchronized cardioversion) and CPR under hemodynamic instability, with implantable cardioverter-defibrillators (ICD) serving as the mainstay for long-term prophylaxis, keeping in mind that all wide QRS tachycardias must be managed as VT until proven otherwise.
References
Wu J, Schuessler RB, Rodefeld MD, Saffitz JE, Boineau JP. Morphological and membrane characteristics of spider and spindle cells isolated from rabbit sinus node. Am J Physiol Heart Circ Physiol. 2001 Mar;280(3):H1232-40
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC),European Heart Journal (2016) 37, 2893–2962
Boersma LV, Schmidt B, Betts TR, et al. EWOLUTION investigators. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J 2016;37:2465–2474.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. JACC 2006;48:247-346.
Moss AJ, Greenberg H, Case RB, et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 2004;110:3760–5.
Akhtar M. Electrophysiologic bases for wide QRS complex tachycardia. Pacing Clin Electrophysiol 1983;6:81– 98.